Jill Reckless
individual
About
Jill Reckless is a biotech operator and translational-science advisor best known as CEO and co-founder of RxCelerate, a drug discovery and development services company she co-founded in 2013 with David Grainger. Her background spans translational biology, therapeutic program design, and client-facing strategy for biotech and pharma companies. In March 2025, Shift Bioscience appointed her as Translation Advisor to help guide indication selection and therapeutic translation for rejuvenation programs.
Areas of interest
biotechdrug discoverytranslational biologyclinical developmentlongevityage-related disease therapeuticsAI in biotech